Abstract:Background Gene therapy using a recombinant adenovirus (Ad) encoding secretory human endostatin (Ad-Endo) has been demonstrated to be a promising antiangiogenesis and antitumor strategy of in animal models and clinical trials. The E1B55KD-deficient Ad dl 1520 was also found to replicate selectively in and destroy cancer cells. In this study, we aimed to investigate the antitumor effects of antiangiogenic agent Ad-Endo combined with the oncolytic Ad dl 1520 on gastric cancer (GC) in vitro and in vivo and determine the mechanisms of these effects. Methods The Ad DNA copy number was determined by real-time PCR, and gene expression was assessed by ELISA, Western blotting or immunohistochemistry. The anti-proliferation effect (cytotoxicity) of Ad was assessed using the colorimetry-based MTT cell viability assay. The antitumor effects were evaluated in BALB/c nude mice carrying SGC-7901 GC xenografts. The microvessel density and Ad replication in tumor tissue were evaluated by checking the expression of CD34 and hexon proteins, respectively. Results dl 1520 replicated selectively in GC cells harboring an abnormal p53 pathway, including p53 mutation and the loss of p14 ARF expression, but did not in normal epithelial cells. In cultured GC cells, dl 1520 rescued Ad-Endo replication, and dramatically promoted endostatin expression by Ad-Endo in a dose- and time-dependent manner. In turn, the addition of Ad-Endo enhanced the inhibitory effect of dl 1520 on the proliferation of GC cells. The transgenic expression of Ad5 E1A and E1B19K simulated the rescue effect of dl 1520 supporting Ad-Endo replication in GC cells. In the nude mouse xenograft model, the combined treatment with dl 1520 and Ad-Endo significantly inhibited tumor angiogenesis and the growth of GC xenografts through the increased endostatin expression and oncolytic effects. Conclusions Ad-Endo combined with dl 1520 has more antitumor efficacy against GC than Ad-Endo or dl 1520 alone. These findings indicate that the combination of Ad-mediated antiangiogenic gene therapy and oncolytic Ad therapeutics could be one of promising comprehensive treatment strategies for GC.

Effective Gene-Viral Therapy For Telomerase-Positive Cancers By Selective Replicative-Competent Adenovirus Combining With Endostatin Gene

Gene-Viral Cancer Therapy Using Dual-Regulated Oncolytic Adenovirus with Antiangiogenesis Gene for Increased Efficacy

Development of gene-viral therapeutic system CNHK300-mE and its primary study in vitro

Effective Inhibition Of Cancer Cells By Recombinant Adenovirus Expressing Egfr-Targeting Artificial Microrna And Reversed-Caspase-3

Gene therapy with recombinant adenovirus encoding endostatin encapsulated in cationic liposome in coxsackievirus and adenovirus receptor-deficient colon carcinoma murine models.

Adenovirus-Mediated Combined Anti-Angiogenic and Pro-Apoptotic Gene Therapy Enhances Antitumor Efficacy in Hepatocellular Carcinoma

Antiangiogenesis Gene Armed Tumor‐targeting Adenovirus Yields Multiple Antitumor Activities in Human HCC Xenografts in Nude Mice

Potent Antitumor Efficacy Of An E1b 55kda-Deficient Adenovirus Carrying Murine Endostatin In Hepatocellular Carcinoma

Inhibition of Tumor Growth in Xenografted Nude Mice with Adenovirus-Mediated Endostatin Gene Comparison with Recombinant Endostatin Protein.

Endostatin Gene Therapy for Liver Cancer by a Recombinant Adenovirus Delivery

Suppression of Ovarian Cancer Growth Via Systemic Administration with Liposome-Encapsulated Adenovirus-Encoding Endostatin

Establishment of a gene-viral therapeutic system CNHK200-hA and its anti- tumor effect on colon cancer

Antitumor Efficacy of a Recombinant Adenovirus Encoding Endostatin Combined with an E1B55KD-deficient Adenovirus in Gastric Cancer Cells

A New Oncolytic Adenoviral Vector Carrying Dual Tumour Suppressor Genes Shows Potent Anti-Tumour Effect

Anti-tumor Effect of Gene-Viral Therapeutic System CNHK300-murine Endostatin on Nude Mouse Gastric Cancer

A Novel Oncolytic Adenovirus Expressing Escherichia Coli Cytosine Deaminase Exhibits Potent Antitumor Effect on Human Solid Tumors

Co-expression of Herpes Simplex Virus Thymidine Kinase and Escherichia Coli Nitroreductase by an Htert-Driven Adenovirus Vector in Breast Cancer Cells Results in Additive Anti-Tumor Effects.

[Cnhk200-Ha-a Gene-Viral Therapeutic System and Its Antitumor Effect on Lung Cancer].

Therapeutic Efficacy Of An Htert Promoter-Driven Oncolytic Adenovirus That Expresses Apoptin In Gastric Carcinoma

Anti-tumor Effect of Adenovirus-Mediated Suicide Gene Therapy under Control of Tumor-Specific and Radio-Inducible Chimeric Promoter in Combination with Γ-Ray Irradiation in Vivo

Synergistic Antitumor Efficacy of Oncolytic Adenovirus Combined with Chemotherapy